阿尔及利亚构建医药自主体系

Core Insights - Algeria is advancing its pharmaceutical sovereignty strategy, achieving significant progress in key areas such as insulin, anticancer drugs, and hormone medications, while gradually exporting domestically produced medicines to multiple African countries [1] Industry Development - The Algerian Ministry of Pharmaceutical Industry is focusing on expanding local production capacity and attracting global pharmaceutical companies' technologies, with health sovereignty as a core aspect of its industrial policy [1] - Algeria has established strategic partnerships with several leading international laboratories to acquire the latest innovations in pharmaceutical technology [1] Production Capacity - The country has approved 100 new pharmaceutical production projects, which will significantly enhance local production capabilities and improve the quality of domestically produced medicines [1] - Algeria currently has over 230 pharmaceutical companies and 780 production lines, indicating a robust growth in the pharmaceutical sector and reflecting the country's ambition to become a key pharmaceutical hub in Africa and the Mediterranean region [1]